The same study revealed that 24% of people ... to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro ...

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same time, is able to reduce inflammation.

"Second, the metabolic regulation and improvement in metabolic health from these medications, including lowering blood glucose levels and decreasing insulin ... drug included in the study was ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin ...

A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, according to a multinational study ...

A new study found that GLP-1 drugs significantly reduce cancer risk ... “They also enhance insulin sensitivity and lower insulin levels, decreasing cancer cell growth signals.” ...

Ohio came in sixth place, seeing an average of 40.8 fatal drug overdose deaths per 100,000 residents each year. This number is 48% above the national average of 27.5, according to the study.

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

The active ingredient in the popular weight loss drug Wegovy may help treat ... reduce body fat and improve insulin sensitivity, the study authors suggested. These changes can ease the strain ...